Vincent Romanet

1.9k total citations
13 papers, 513 citations indexed

About

Vincent Romanet is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Vincent Romanet has authored 13 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Genetics. Recurrent topics in Vincent Romanet's work include Cytokine Signaling Pathways and Interactions (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Kruppel-like factors research (3 papers). Vincent Romanet is often cited by papers focused on Cytokine Signaling Pathways and Interactions (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Kruppel-like factors research (3 papers). Vincent Romanet collaborates with scholars based in Switzerland, United States and United Kingdom. Vincent Romanet's co-authors include Masato Murakami, Thomas Radimerski, Rita Andraos, Mohamed Bentires‐Alj, Heike Brinkhaus, Urs Müller, Adrian Britschgi, Ina Klebba, Francesco Hofmann and Dario Sterker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Vincent Romanet

13 papers receiving 506 citations

Peers

Countries citing papers authored by Vincent Romanet

Since Specialization

Citations

This map shows the geographic impact of Vincent Romanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Romanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Romanet more than expected).

Fields of papers citing papers by Vincent Romanet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Romanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Romanet. The network helps show where Vincent Romanet may publish in the future.

Co-authorship network of co-authors of Vincent Romanet

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Romanet. A scholar is included among the top collaborators of Vincent Romanet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Romanet. Vincent Romanet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	QSP modeling of a transiently inactivating antibody-drug conjugate highlights benefit of short antibody half life 2024 ·Journal of Pharmacokinetics and Pharmacodynamics ·Eshita Khera, (unknown), Dominik Hainzl, (unknown), (unknown), J. J. Davis, Nicolas Ebel, (unknown), Vincent Romanet, (unknown), Jeffrey D. Kearns	3
2	PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer 2023 ·Journal of Mammary Gland Biology and Neoplasia ·(unknown), (unknown), (unknown), Marie‐May Coissieux, (unknown), Vincent Romanet, Atul Sethi, Baptiste Hamelin, Bogdan‐Tiberius Preca, Salvatore Piscuoglio, Charlotte K.Y. Ng, Morvarid Mohseni, Mohamed Bentires‐Alj	7
3	HistoNet: A Deep Learning-Based Model of Normal Histology 2021 ·Toxicologic Pathology ·Hölger Hoefling, Tobias Sing, Imtiaz Hossain, Julie Boisclair, Arno Doelemeyer, Thierry Flandre, Alessandro Piaia, Vincent Romanet, (unknown), Chandrassegar Saravanan, Esther Sutter, Oliver C. Turner, (unknown), Pierre Moulin	19
4	JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis 2016 ·Blood ·Jean Grisouard, Sai Li, Lucia Kubovčáková, Tata Nageswara Rao, Sara C. Meyer, Pontus Lundberg, Hui Hao-Shen, Vincent Romanet, Masato Murakami, Thomas Radimerski, Stephan Dirnhofer, Radek C. Skoda	28
5	Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells – a preclinical MR study in mice 2014 ·BMC Cancer ·Claudia Weidensteiner, Peter R. Allegrini, (unknown), Vincent Romanet, Stéphane Ferretti, (unknown)	24
6	JAK1/2 and Pan-Deacetylase Inhibitor Combination Therapy Yields Improved Efficacy in Preclinical Mouse Models of JAK2V617F-Driven Disease 2013 ·Clinical Cancer Research ·(unknown), Nicolas Ebel, Vincent Romanet, (unknown), Rita Andraos, (unknown), (unknown), Ernesta Dammassa, Dario Sterker, Robert Cozens, Francesco Hofmann, Masato Murakami, Fabienne Baffert, Thomas Radimerski	59
7	Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors 2013 ·PLoS ONE ·Simon Wöhrle, Andreas Weiss, Moriko Ito, Audrey Kauffmann, Masato Murakami, Zainab Jagani, (unknown), (unknown), (unknown), Christelle Stamm, Astrid Pornon, Vincent Romanet, Vito Guagnano, Thomas Brümmendorf, William R. Sellers, Francesco Hofmann, Charles W.M. Roberts, Diana Graus Porta	39
8	Abstract LB-36: JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: A rationale for co-targeting these pathways in metastatic breast cancer. 2013 ·Cancer Research ·Adrian Britschgi, Rita Andraos, Heike Brinkhaus, (unknown), Masato Murakami, Vincent Romanet, Urs Müller, Thomas Radimerski, Mohamed Bentires‐Alj	1
9	K-RAS Mutant Pancreatic Tumors Show Higher Sensitivity to MEK than to PI3K Inhibition In Vivo 2012 ·PLoS ONE ·Irmgard Hofmann, Andreas Weiss, Gaëlle Elain, Maria Schwaederlé, Dario Sterker, Vincent Romanet, Tobias Schmelzle, Albert Lai, Saskia M. Brachmann, Mohamed Bentires‐Alj, Thomas M. Roberts, William R. Sellers, Francesco Hofmann, Sauveur-Michel Maira	58
10	JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer 2012 ·Cancer Cell ·Adrian Britschgi, Rita Andraos, Heike Brinkhaus, Ina Klebba, Vincent Romanet, Urs Müller, Masato Murakami, Thomas Radimerski, Mohamed Bentires‐Alj	193
11	Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model 2012 ·Blood ·Lucia Kubovčáková, Pontus Lundberg, Jean Grisouard, Hui Hao-Shen, Vincent Romanet, Rita Andraos, Masato Murakami, Stephan Dirnhofer, Kay‐Uwe Wagner, Thomas Radimerski, Radek C. Skoda	32
12	Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition 2012 ·Proceedings of the National Academy of Sciences ·Aleksandra Bielen, Gary Box, Lara Perryman, Lynn Bjerke, Sergey Popov, Yann Jamin, Alexa Jury, Melanie Valenti, Alexis de Haven Brandon, Vanessa Martins, Vincent Romanet, Sébastien Jeay, Florence I. Raynaud, Francesco Hofmann, Simon P. Robinson, Suzanne A. Eccles, Chris Jones	28
13	Improved Efficacy Upon Combined JAK1/2 and Pan-Deacetylase Inhibition Using Ruxolitinib (INC424) and Panobinostat (LBH589) in Preclinical Mouse Models of JAK2V617F-Driven Disease 2011 ·Blood ·Fabienne Baffert, (unknown), Nicolas Ebel, (unknown), Rita Andraos, (unknown), Vincent Romanet, Masato Murakami, Thomas Radimerski	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact